Expert Directory

Clear Filters

Igor Puzanov, MD

Director of Early Phase Clinical Trials Program an

Roswell Park Comprehensive Cancer Center

Novel Therapies, Melanoma, immunotheraphy, Cancer Vaccines, Personalized Medicine, Cancer

His role as a Clinical Professor of Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Professor of Medicine and Director of Early Phase Clinical Trials Program in the Department of Medicine at Roswell Park Comprehensive Cancer Center, He is developing novel therapies for patients with cancer. This includes clinical trials from the early pre-clinical phase through phase I/II/III with emphasis on a combination of immune and targeted agents, novel drug design, including histology-agnostic trial development of targeted therapies. He also provides advice on regulatory requirements and necessary steps associated with advancing drugs, devices, and imaging agents toward clinical trials in patients.

In his professional career, I have focused both on developing precision medicine agents as well as immunotherapies. In the first-in-human trial of PLX4032/vemurafenib, our team has provided critical PK/PD data that led to the first in class/ first in human FDA-approved BRAF inhibitor. His interest and expertise in immunotherapy started in the early 1990s with animal models of IL-2 and IL-15 cytokines and natural killer cell development, continued with high dose IL-2 studies, and subsequently Phase I-III trials with both CTLA-4 and PD1/PDL-1 checkpoint inhibitors. Our team was instrumental in the development of talimogene laherparepvec, the first in human oncolytic virus therapy for patients with melanoma. Recently, we have explored immunotherapy combinations with targeted agents as well as combinations of oncolytic viruses with checkpoint inhibitors.

Our work was instrumental in several FDA approvals of breakthrough anti-cancer drugs (vemurafenib, dabrafenib+trametinib, vemurafenib+cobimetinib, pembrolizumab, talimogene laherparepvec) and resulted in almost 100 manuscripts, including New England Journal of Medicine, Lancet, Journal of Clinical Oncology, JAMA, Nature. I am a member of American Society of Medical Oncology, Society of Immunotherapy in Cancer, ACP, AACR and Society of Melanoma Research and serve as an editor and reviewer for several peer reviewed journals.

Mary Reid, MSPH

Director of Cancer Screening and Survivorship

University of Vermont

Cancer, Lung Cancer, Cancer Screening, Cancer Detection, Cancer Prevention, Epidemiology

Director of Cancer Screening and Survivorship, Roswell Park Cancer Institute
Areas of expertise: Lung cancer, cancer screening, cancer early detection, epidemiology, cancer prevention

Tom Smith, LLB, PhD

Senior Lecturer in International Relations

University of Portsmouth

Terrorism, political violence, Insurgency, transnational criminal groups

Tom is a Lecturer in International Relations for the University of Portsmouth based at the Royal Air Force College Cranwell. He specializes in terrorism, political violence, and insurgencies with a focus on Southeast Asia but more broadly on jihadist (al Qaeda, ISIS, etc.) and political violence related to transnational Islam. He has fieldwork experience in Mindanao in the Philippines and Southern Thailand and is regularly asked by development, conflict and governmental organizations to contribute to research design, project planning and for advice. A former Visiting Lecturer at De La Salle University in Manila, Tom has worked across Asia in conflict environments for NGOs, charities and IGOs. Tom is best known on an international basis for his expertise on the Abu Sayyaf Group in the Southern Philippine province of Mindanao but has also become perhaps one of the UKs most recognised authorities on Filipino politics and Filipino foreign affairs.

Michael Tipton

Professor of Human & Applied Physiology

University of Portsmouth

Psychological, Physiological, Survival

He has spent over 30 years researching and advising in the areas of thermoregulation, environmental and occupational physiology and survival in the sea. He has published over 400 scientific papers, reports, chapters and books in these areas. Professor Tipton is a consultant in survival and thermal medicine to the Royal Air Force and UKSport; he sits on the Royal National Lifeboat Institution’s Medical & Survival Committee, Surf Lifesaving GB’s medical and research advisory panel and the Ectodermal Dysplasia Society’s medical advisory board. He Chairs UKSport’s Research Advisory Group which oversees all medical and technological research undertaken with and for Team GB’s athletes.

Professor Tipton provides advice to a range of universities, government departments, industries, medical, search and rescue and media organizations.

Karen Masters, PhD

Reader in Astronomy and Astrophysics

University of Portsmouth

Galaxy Formation, Galaxy Evolution, galaxy kinematics and dynamics, Morphology, Citizen Science

Research interests: Galaxy formation and evolution. Galaxy kinematics. Galaxy morphologies. Citizen Science (especially in Astronomy). 
Karen's interests are in the area of extragalactic astronomy. She studies how galaxies formed and evolve in our universe using data from large surveys like the Sloan Digital Sky Survey. She is the Project Scientist for Galaxy Zoo and often uses information on galaxy shapes and types collected from this citizen science project in her research.

Peter Lee

Reader in Politics and Ethics

University of Portsmouth

Drone, drone operations, Politics, Ethics, Military intervention

Dr Peter Lee is a University of Portsmouth Reader in Politics and Ethics who specializes in the ethical and operational aspects of remotely piloted aircraft (drone) operations, as well as the politics and ethics of war and military intervention. He writes in various formats with a particular focus on the UK’s Royal Air Force Reaper drone squadrons.

Between July and December 2016 he was granted unprecedented research access by the Royal Air Force to British Reaper drone operations at both RAF Waddington in Lincolnshire, UK and Creech Air Force Base outside Las Vegas, Nevada. He was able to observe both surveillance and lethal missile strikes against Islamic State jihadists in Syria and Iraq: in real time and in close-up detail. He has also conducted in-depth interviews with 70 members of the Royal Air Force Reaper drone community for his next book, Reaper Force: The Inside Story of Britain’s Drone Wars. Peter is regularly invited to lecture on this and other subjects to military, academic, political, religious, media and wider audiences.

From June 2015 to June 2016 he was a member of the Department for Transport Oversight Committee for the Sciencewise public dialogue: The Use and Development of Remotely Piloted Aircraft Systems and Small Drones in the United Kingdom, which preceded the current government consultation on drones. In 2012 he published Blair’s Just War: Iraq and the Illusion of Morality and in 2015 published Truth Wars: The Politics of Climate Change, Military Intervention and Financial Crisis, both with Palgrave Macmillan.

Lina Begdache, PhD

Assistant Professor of Health and Wellness Studies

Binghamton University, State University of New York

Nutrigenomics, Neurodegeneration, Nutrition, Mental Distress, Microbiota, Food

Lina Begdache, assistant professor of health and wellness studies at Binghamton University, has been featured by publications such as Bustle, The New York Post, Newsweek and more for her research around food and mood/stress. Her research interests include nutrigenomics and nutrigenetics, neurodegeneration, nutrition and mental distress, and microbiota.

Neil B. Friedman, MD, FACS

Director, The Hoffberger Breast Center at Mercy

Mercy Medical Center

Cancer, Breast Cancer, Research, Womens Health, intraoperative radiotherapy

Neil B. Friedman, M.D., FACS, is Director of The Hoffberger Breast Center at Mercy as well as Medical Director of The Weinberg Center for Women's Health and Medicine at Mercy. As a catalyst for advancing breast cancer treatment, Dr. Friedman has partnered with many prestigious national and local organizations to improve the treatment options for women with breast cancer. Likewise, on a very personal level, he partners with each of his patients and their families to help them face the challenges and triumphs of living with a breast cancer diagnosis. Dr. Friedman led the charge to bring IORT, Intraoperative Radiotherapy, to Mercy making it the first hospital in Maryland to offer this leading-edge technology. 
Dr. Friedmane began his medical career as Chief Resident at the nationally renowned Memorial Sloan-Kettering Cancer Center in New York.  He is a Board Certified breast cancer doctor who is dedicated to the search for a cure for cancer. His team continues to lead breast cancer initiatives and introduce best-in-practice breast care treatment options, including Intraoperative Radiotherapy (IORT), an innovative, single-dose radiation treatment, to patients.  Dr. Friedman was named Humanitarian of the Year by the Mildred Mindell Cancer Foundation for his efforts in the fight against breast cancer. He has served as a national spokesperson for breast cancer prevention for major organizations such as Bath & Bodyworks.
Dr. Friedman has been the Chairman of the American Cancer Society’s Research Administrative Committee, a member of its Executive and Professional Education Committees, and served on its Board of Directors. He has also been involved with the Susan G. Komen Breast Cancer Foundation.
Dr. Friedman leads a team of clinicians devoted to breast cancer education, advocating the latest advancements in diagnosis and treatment of breast cancer at a number of conferences, continuing education forums, and patient seminars.
Dr. Neil Friedman remains committed in his career to find optimal treatments for breast cancer. Some of his accomplishments include:
•	Named a “Top Doc” by Baltimore magazine in the Breast Surgery category
•	Named Humanitarian of the Year by the Mildred Mindell Cancer Foundation
•	The Breast Center at Mercy Medical Center first in Maryland to offer IORT Treatment
•	Research on cancer has been published in American Journal of Public Health(APHA) and the Journal of Immunotherapy

Armando Sardi, MD, FACS

Medical Director, The Institute for Cancer Care at Mercy Chief, Division of Surgical Oncology

Mercy Medical Center

Thyroid Cancer, Oncologist, Hyperthermic Intraperitoneal Chemotherapy, Cancer, medical director

Armando Sardi, M.D., is a respected and renowned Surgical Oncologist who has been honored as a Top Doc in Baltimore magazine multiple times. He serves as Medical Director of The Institute for Cancer Care at Mercy and as Chief of Division of Surgical Oncology at Mercy Medical Center in Downtown Baltimore, Maryland. Dr. Sardi is one of Maryland’s leading surgical oncologists who use Hyperthermic Intraperitoneal Chemotherapy (HIPEC) to treat late-stage, complex cancers of the abdominal region. Dr. Sardi has been performing HIPEC procedures since 1994 and is considered to be among the best doctors using the technique. This advanced heated chemotherapy procedure is often a life-saving treatment option for patients who have exhausted more traditional treatment plans for stomach cancer. Patients have traveled to Mercy Medical Center from points up and down the East Coast to destinations across the U.S., to seek out Dr. Sardi for his cancer expertise in the HIPEC treatment.

Dr. Armando Sardi is a man whose professional focus is devoted to medical excellence, research and finding a cure for cancer. For his patients, Dr. Sardi’s personal concern and approach to their care are what helps them gain a positive outlook and confidence to face the challenges ahead. His cheerful smile and kind-hearted laugh immediately put patients at ease. And yet, his unyielding determination to give every patient the best possible chance to overcome their illness that ranks him among the best of the best. When other doctors have told patients there is no hope, Dr. Sardi tries even harder to beat the odds. Thanks to Dr. Sardi, the HIPEC procedure and other leading-edge treatment options, he has given patients so much more than hope. Patient after patient, year after year, have shared their stories at Mercy’s National Cancer Day Survivor Celebration and Mercy's annual Heat It to Beat It fundraising event. There are 3, 5, 10-year cancer survivors – each telling a heartwarming story of hope and survivorship. Dr. Sardi co-chair Mercy’s Cancer Committee and actively participates in The Tumor Board. These efforts allow cancer experts, specialists and key members of the healthcare team to discuss and collaborate on complex cancer cases to learn new and different ways to optimize resources, medical knowledge and treat patients so that long-term results will be improved.
Dr. Sardi also plays a key role in the Mercy National Cancer Survivor Day festivities. This joyous and spirited celebration is more than a reunion of cancer survivors, it is a day when Dr. Sardi and the Mercy family rejoice with their patients and loved ones. Together they have been through a long and challenging cancer journey and together they delight in all the possibilities ahead.
Dr. Armando Sardi, whose celebrated reputation has garnered local and international acclaim, has earned an international reputation for the advances he has made in the surgical oncology field and for his humanitarian efforts to care for the poor and underserved in third world countries. 
Dr. Sardi has been distinguished in Colombia, South America as one of the 100 Most Influential Expatriates – an honor received, in part, for the medical care he provides through the non-profit organization, Partners for Cancer Care and Prevention. This organization was the recipient of the Conquer Cancer Foundation's Inaugural International Innovation Grant.
Dr. Armando Sardi has been recognized for his research, leadership and compassionate bedside manner. Some of his awards include:

“Hispanic Hero Award for Excellence as a Medical/Social Entrepreneur”  Presented by USHYEE
“Gold Star Teamwork Award” Presented by The Sisters of Mercy in recognition of Gold Star performance
Honored by Fusionarte as one of “100 Colombianos” who represent the talent, creativity, and perseverance of Colombia. Bogota, Colombia December 2012
Named by Baltimore Magazine a "Top Doctor" in the Surgical Oncology specialty
Named by Castle Connelly Medical Ltd. a "Top Doctor" in Surgery
Dr. Sardi founded the annual HEAT IT TO BEAT IT benefit walk in Baltimore to raise awareness about HIPEC and cancer treatment.

Laxmi Mehta, MD

Director, Preventative Cardiology and Women's Hear

Ohio State University Wexner Medical Center

Women's Heart Health, Women's Heart Disease, preventative cardiology, Cardiovascular Disease Prevention, Cardiovascular Disease, cardiovascular disease and women, Cardiac Rehabilitation, Cardiac Imaging

Laxmi Mehta, M.D., FACC, FAHA is the Director of the Women’s Cardiovascular Health Program and an Associate Professor of Medicine at The Ohio State University Wexner Medical Center. Dr. Mehta is also the Associate Program Director for Education for Ohio State’s Center for Women’s Health. 

She is the President of the Ohio Chapter of the American College of Cardiology and has previously served two terms as Secretary/Treasurer for the Ohio-ACC Chapter. Additionally, she is the Immediate Past President of the metro Columbus Board of Directors for the American Heart Association and now currently serves on the Great Rivers Affiliate Board for the American Heart Association. She sits on several national committees for both the American College of Cardiology and the American Heart Association. Dr. Mehta was chosen by Business First Magazine as one of Columbus' Top 40 under 40 in 2010 and honored as one of 12 women for the 2012 Women for Economic Leadership (WELD) Women You Should Know Calendar Honoree. 

She specializes in women’s cardiovascular health, prevention and cardiac imaging. Dr. Mehta is an avid promoter and educator on women’s cardiovascular health and has published a number of peer-reviewed articles and book chapters. She is a Fellow of the American College of Cardiology and the American Heart Association. She received her M.D. degree from Northeastern Ohio Universities Colleges of Medicine and Pharmacy in Rootstown, Ohio in 1998. She completed her Internal Medicine residency training and Clinical Cardiology fellowship training at William Beaumont Hospital in Royal Oak, Michigan in 2001 and 2005. 

Ken Yeager, PhD, LISW

Psychologist and Director, Stress Trauma and Resil

Ohio State University Wexner Medical Center

Mental Health, Behavioral Health, Stress, stress and health, Stress and Anxiety, Stress And Depression, trauma exposure, addiction treatment, Family Stress, work stress

Clinical Director of the Stress, Trauma and Resilience (STAR) program at Ohio State. 

Brad Lander, PhD

Psychologist & Clinical Director of Addiction Medi

Ohio State University Wexner Medical Center

opoid addiction, Addiction Medicine, Alcohol Addiction, Drug Addiction, addiction treatment

---
Pradeep K. Khosla
Chancellor, University of California San Diego

Pradeep K. Khosla, UC San Diego’s eighth Chancellor, is an internationally renowned electrical and computer engineer recognized for his seminal contributions in intelligent robot systems and design. He provides vision and strategy for the university, leading a campus with more than 35,000 students, six undergraduate colleges, five academic divisions, five graduate and professional schools, a preeminent Health System and the prestigious Scripps Institution of Oceanography.  

Khosla initiated and led UC San Diego’s first-ever Strategic Plan, and recently launched the public phase of the Campaign for UC San Diego—an ambitious and bold $2 billion endeavor—aimed at transforming the university, physically and intellectually. Khosla has expanded college access and affordability for underserved populations, initiated interdisciplinary research initiatives to foster collaboration and solve societal challenges, and strengthened university and community relationships and partnerships. 

Previously, Khosla served as Dean of the College of Engineering and Philip and Marsha Dowd University Professor at Carnegie Mellon University. He spent the majority of his career at Carnegie Mellon, rising through the ranks from his first position as Assistant Professor in 1986 to his appointment as Dean in 2004. From 1994 to 1996, he also served as a Defense Advanced Research Projects Agency (DARPA) Program Manager in the Software and Intelligent Systems Technology Office, Defense Sciences Office and Tactical Technology Office, where he managed advanced research and development programs.

Khosla is an elected member of the American Academy of Arts and Sciences, National Academy of Engineering and the American Society for Engineering Education. He is a Fellow of the Institute of Electrical and Electronics Engineers, the American Society of Mechanical Engineers, the American Association for Advancement of Science, the American Association of Artificial Intelligence and the Indian Academy of Engineering. He is an Honorary Fellow of the Indian Academy of Science. 

The recipient of numerous awards for his leadership, teaching and research, Khosla has received the 2012 Light of India Award, a Lifetime Achievement Award from the American Society of Mechanical Engineers, and the George Westinghouse Award for contributions to improve engineering teaching. In 2012, he was named as one of the 50 most influential Indian-Americans by SiliconIndia.

Khosla received his bachelor’s degree in electrical engineering from the Indian Institute of Technology - Kharagpur in 1980, and his M.S. and Ph.D. degrees in electrical and computer engineering in 1984 and 1986 at Carnegie Mellon. In 2014, he received an honorary doctorate of science from the Indian Institute of Technology - Kharagpur.

John-Paul Rue, MD

Fellowship-trained Board Certified orthopedic sports medicine surgeon

Mercy Medical Center

Orthopedic Sports Medicine, Orthopedic Surgery, Sports Medicine, Sport

John-Paul Rue, M.D., is a fellowship-trained Board Certified orthopedic sports medicine surgeon, specializing in arthroscopic repair of sports-related injuries, including complex knee and shoulder reconstructions with Orthopedics and Joint Replacement at Mercy. Dr. John-Paul Rue specializes in the prevention and treatment of injuries related to sports and exercise. He treats patients of all ages, serving athletes ranging from the casual jogger or weekend warrior to competitive and collegiate athletes and beyond. His primary focus is treating injuries of the knee, shoulder, and elbow, from ACL tears, meniscus and cartilage injuries to shoulder instability and rotator cuff injuries. He also sees patients with injuries such as overuse tendonitis, ankle sprains, and fractures. As an orthopedic surgeon and sports medicine specialist, Dr. Rue is able to diagnose and treat a wide variety of acute and overuse injuries utilizing both surgical and non-operative techniques. He works closely with colleagues and rehabilitation specialists to guide patients through the recovery process, recommend related strength and conditioning exercises and offer return-to-play insight and guidelines. Dr. Rue’s patient-centered approach to treatment and rehabilitation allows him to develop strong doctor-patient relationships and personalized treatment plans for each patient. He is committed to helping his patients perform at their very best when participating in their chosen sports and physical activities. Dr. Rue is a graduate of the United States Naval Academy and served as the head team physician for the Naval Academy before coming to Mercy. He deployed to Iraq with the 1st Marine Expeditionary Force in support of Operation Iraqi Freedom as the Chief Orthopedic Surgeon, Charlie Surgical Company Forward Resuscitative Unit, Camp Fallujah, Iraq and continues his commitment to service as a Naval Reservist. As a respected sports medicine physician, Dr. Rue has contributed numerous print and online publications highlighting his research and experience in the field of orthopedic sports medicine and has given invited lectures on a variety of orthopedic conditions at national and international scientific meetings. His research has garnered 2 major awards from the American Orthopedic Society for Sports Medicine. He is a member of multiple notable medical associations and serves as an expert scientific reviewer for several medical journals, including the American Journal of Sports Medicine, and The Journal of Knee Surgery.

Clifford Jeng, MD

Medical Director, The Institute for Foot and Ankle

Mercy Medical Center

Orthopedic Surgery, Arthritis, Athletic Injuries, Reconstructive Surgery

Clifford L. Jeng, M.D., is Medical Director of The Institute for Foot and Ankle Reconstruction at Mercy Medical Center and an award-winning foot and ankle surgeon. Patients from Baltimore and across the Mid-Atlantic region come to Dr. Jeng for his expertise in foot and ankle injuries and conditions.Dr. Clifford Jeng leads a talented team of surgeons who offer innovative treatments for complex foot and ankle issues as well as comprehensive treatment for common foot and ankle conditions. As a long-standing member of the physician team, Dr. Jeng has invested over a decade in The Institute and continues to carry on the legacy of excellence as its Medical Director. Built on a foundation of continued education and innovation to benefit patient care, The Institute for Foot and Ankle Reconstruction at Mercy remains a leading Center of Excellence in complete foot and ankle care including treatment for ankle injury and Achilles tendon problems, foot injury and conditions, big toe and smaller toe problems, heel injury and diabetic foot conditions.Dr. Jeng and his team offer comprehensive initial visits as well as second opinions. Physicians and patients alike value Dr. Jeng's expert opinion and hopeful patients have been known to travel long distances to be evaluated and cared for by Dr. Jeng.
Various media outlets and television stations also rely on Dr. Jeng to provide thorough analysis and explanation of foot and ankle conditions as well as information on the latest technologies and techniques offering new hope to patients with complicated foot and ankle injuries or problems.
Dr. Jeng has been recognized as a Top Doc by Baltimore magazine multiple times. Board Certified, Dr. Jeng has specialized training in advanced surgical techniques, including minimally invasive surgery and arthroscopy. Dr. Clifford Jeng established the prestigious Foot and Ankle Fellowship program at Mercy and has trained peers and elite orthopedic surgeons.
Following the spirit and mission of the Sisters of Mercy, Dr. Clifford Jeng is dedicated to providing foot and ankle care to the less fortunate in the Baltimore community. Dr. Jeng, along with fellow surgeons Dr. John Campbell and Dr. Rebecca Cerrato, has volunteered foot care services during an annual event for homeless men who find refuge at Baltimore’s Helping Up Mission. Additionally, Dr. Jeng has regularly participated in Baltimore's Run to Remember, running alongside colleagues, patients and Baltimore residents to honor the heroes of 9-11 and raise money for The Baltimore City Police Foundation and The Baltimore City Fire Foundation.

Teresa Diaz-Montes, MD, MPH, FACOG

Associate Director, The Lya Segall Ovarian Cancer

Mercy Medical Center

Gynecologic Oncology, Gynecology, Gynecologic Surgery, Gynecologic Cancer, Fertility

Teresa P. Diaz-Montes, M.D., MPH, FACOG, serves as the Associate Director of The Lya Segall Ovarian Cancer Institute. She also is a noted expert and gynecologic oncologist with The Gynecologic Oncology Center at Mercy, a leading Center in Baltimore for the treatment of cancers of the female reproductive tract. Dr. Teresa Diaz-Montes provides diagnosis and treatment for gynecologic cancers including ovarian cancer, cervical cancer, uterine cancer, vaginal cancer, and vulvar cancer. Board Certified in Gynecologic Oncology, Dr. Teresa Diaz-Montes provides treatment for a diverse range of gynecologic cancers. Her primary clinical interests include ovarian cancer treatments, minimally invasive gynecologic surgery, including robotic surgery, and patient safety and quality. Additional areas of interest include cervical cancer, fallopian tube cancer, fertility-sparing surgery and uterine, vaginal and vulvar cancers. Bringing a friendly approach to the treatment of her patients, Dr. Diaz-Montes takes the necessary time to listen to the needs of her patients and address their concerns. As a recipient of the Patient's Choice award, her approachable, caring bedside manner has been formally recognized by her patients. Dr. Teresa Diaz-Montes is known for her knowledge and dedication to finding advanced treatments for gynecologic cancers. Her expert opinion is often sought by media outlets and she has been featured in notable publications such as The Wall Street Journal and The New York Times. She was also featured by The Sun Magazine as "One of 50 Women to Watch" for her dedication to innovative treatments for ovarian cancer. Dr. Diaz-Montes has extensive experience in research and resident teaching activities. She has conducted various clinical trials to advance the care of gynecologic cancers, particularly ovarian cancer. She and colleagues in The Institute for Cancer Care at Mercy are conducting the first clinical study in the United States regarding the treatment of ovarian cancer with hyperthermic intraperitoneal chemotherapy, also known as HIPEC. Dr. Diaz-Montes, an author and international lecturer, has numerous clinical publications related to women’s cancer treatment to her credit.
Awards and Honors
Top Doctor in Gynecologic Oncology, Baltimore magazine
Top Doctor in Gynecologic Oncology, Castle Connolly Medical Ltd.

Trauma, Mental Health, Anxiety, Stress, Sexual Violence, Suicide, Posttraumatic Stress Disorder, Depression, Military personnel, service use, Intervention

In 2008, Heidi Zinzow joined Clemson’s College of Behavioral, Social and Health Sciences as an assistant professor in the Department of Psychology, bringing her knowledge as a licensed clinical psychologist into the classroom. Her work addresses factors that put individuals at risk of developing psychological symptoms due to trauma exposure, how to ameliorate related mental health symptoms and what the protective factors are. Applying science to practice and vice versa, she focuses on the development of intervention and prevention programs to improve a victim’s well-being, quality of life, and occupational and social functioning.

Zinzow’s in-depth understanding of different types of trauma spans sexual assault, interpersonal violence and mass violence. She examines trauma-related mental health outcomes including post-traumatic stress disorder and depression. Additionally, she has moved into substance use disorders –and risky substance use –as a mechanism for violence perpetration and exposure. Another stream of her research is suicide prevention: how to develop efficacious programs that improve community members’ abilities to identify those at risk, ask difficult questions and provide support. 

With intervention and prevention program development, she examines technology-based tools such as virtual reality, online methodologies and digital apps to deliver programming. Along with other novel applications of technology to help advance the field, Zinzow looks at the role of social media and the propagation of harmful behavior. 

In clinical practice, she has analyzed intergenerational transmission of trauma, substance use and mental illness and how these variables affect each other. Working with the military, she has explored mental health and exposure to stress, combat and trauma, including military sexual assault. An as an expert consultant, she has investigated ways to work with communities to better address mass violence exposure. 

In collaboration, Zinzow has authored over 50 publications in scientific,peer-reviewed journals, which include “Journal of Traumatic Stress,” “Journal of Interpersonal Violence,” “Clinical Psychology Review” and “Journal of Clinical and Consulting Psychology.”

She co-founded Tigers Together to Stop Suicide, currently serves as an expert consultant for the National Mass Violence and Victimization Resource Center, and helps lead Clemson's NSF Tigers ADVANCE  initiative to improve campus gender equity.  She has received an  Emerging  Scholar Research  Excellence  Award and  Excellence in  Service and  Outreach  Award,  as well as an Outstanding Woman Faculty Member Award from the President's Commission on Women. 

Before joining Clemson, Zinzow completed a postdoctoral fellowship in traumatic stress with the National Crime Victims Research & Treatment Center at the Medical University of South Carolina (MUSC). In addition to her practice as a licensed clinical psychologist, she has served at many domestic violence and sexual assault centers. In her early career, she worked as a research assistant for Caliber Associates in Northern Virginia, outside of Washington, D.C., evaluating social programs that addressed domestic violence, child maltreatment and juvenile delinquency.

drug shortages, Opioids, Medication Safety, Patient Safety, Pediatrics, Critical Care, hospital administration, Healthcare, Pharmacy, Polypharmacy

Deborah A. Pasko, Pharm.D., M.H.A., is the Sr. Director of Medication Safety and Quality at ASHP (American Society of Health-System Pharmacists). With more than 22 years of pharmacy practice experience, Dr. Pasko leads ASHP’s efforts to improve medication safety and reduce opioid misuse. 

Dr. Pasko’s role at ASHP includes working with the Food and Drug Administration (FDA), the National Institutes of Health (NIH), the Department of Health and Human Services (HHS), and the White House on national medication safety initiatives. She also serves as an advisor to the Institute for Safe Medication Practices (ISMP), the Joint Commission (TJC), the United States Pharmacopeia (USP) National Coordinating Council for Medication Error Reporting and Prevention (NCC-MERP) safety committee, and the National Quality Forum (NQF). 

Dr. Pasko earned her Bachelor of Pharmacy degree from the Ohio Northern University College of Pharmacy and her Doctor of Pharmacy degree from Idaho State University College of Pharmacy. She has a Masters of Health Administration from the Walden University School of Health Sciences and completed a fellowship in Nephrology and Critical Care at the University of Michigan College of Pharmacy. Dr. Pasko has received numerous awards including the Cheers Award for Medication Safety. 


Tracy Kijewski-Correa, PhD

Associate Professor of Civil Engineering and Geolo

University of Notre Dame

Modern Civil Infrastructure, Natural Hazard Assessment and Mitigation, disaster risk reduction, engineering for international development

---

Exercise, pain, Fibromyalgia, Osteoarthritis, Pain Measurement

Board certified rheumatologist and a clinical scientist whose area of research is in both the pharmacological and non-pharmacological management of persistent pain. Dr. Ang has been the primary investigator of three National Institute of Health (NIH)-funded clinical trials in fibromyalgia. He has approximately 25 publications in peer reviewed journals in arthritis and pain. Dr. Ang has served as an ad hoc reviewer for NIH, and also a reviewer of research abstracts for the American College of Rheumatology (ACR). He is an active member of both the ACR and the American Pain Society.
close
1.1713